Michael P. Cruse

Michael P. Cruse, Chief Operating Officer

Michael is the Chief Operating Officer of Reneo Pharmaceuticals. Michael brings more than 20 years of biopharmaceutical industry experience in corporation operations, business administration, human resources, commercial operations and information technology. Prior to joining Reneo, Michael was Novus Therapeutics’ (now Eledon Pharmaceuticals) Vice President of Corporate Operations, where he oversaw the daily non-finance general and administrative operations. Michael previously served as the Vice President of Corporate Operations at Otic Pharma Ltd (acquired by Tokai Pharmaceuticals) and the Executive Director of Sales Operations at Avanir Pharmaceuticals (acquired by Otsuka Pharmaceuticals.) Earlier in his career, he co-founded a technology consulting firm focused on bringing technology platforms and business automation to small and mid-market organizations.

Michael holds a Bachelor of Science in Business Administration from Franklin University.